Generated by DeepSeek V3.2| Roderick MacKinnon | |
|---|---|
![]() | |
| Name | Roderick MacKinnon |
| Caption | MacKinnon in 2003 |
| Birth date | 19 February 1956 |
| Birth place | Burlington, Massachusetts |
| Nationality | American |
| Fields | Molecular biology, Biophysics |
| Workplaces | Harvard University, The Rockefeller University |
| Alma mater | Tufts University, Brandeis University |
| Known for | Ion channel structure and function |
| Prizes | Nobel Prize in Chemistry (2003), Albert Lasker Award for Basic Medical Research (1999) |
Roderick MacKinnon is an American structural biologist renowned for his pioneering work in elucidating the three-dimensional architecture and functional mechanisms of ion channels. His research, which fundamentally transformed the fields of neurobiology and cell physiology, earned him the Nobel Prize in Chemistry in 2003. MacKinnon's laboratory at The Rockefeller University has been a leading center for applying X-ray crystallography to membrane proteins, providing atomic-level insights into how ions traverse cell membranes.
Born in Burlington, Massachusetts, MacKinnon developed an early interest in science. He completed his undergraduate education at Tufts University, earning a degree in biochemistry. He then pursued his medical degree at Tufts University School of Medicine, graduating with an M.D. in 1982. Following his clinical training in internal medicine at Beth Israel Deaconess Medical Center in Boston, his scientific curiosity shifted toward fundamental biological mechanisms. He subsequently entered graduate school at Brandeis University, where he earned a Ph.D. in molecular biology under the mentorship of Christopher Miller, a prominent researcher in ion transport.
After completing his Ph.D., MacKinnon established his independent laboratory at Harvard University as an assistant professor in the Department of Neurobiology. His early work focused on the functional characterization of potassium channels using electrophysiology and site-directed mutagenesis. A pivotal moment in his career was his decision to move his research group to The Rockefeller University in 1996, where he dedicated his efforts to determining the high-resolution crystal structure of an ion channel. In 1998, his team achieved a landmark breakthrough by solving the structure of the Streptomyces lividans potassium channel (KcsA), published in the journal Science. This structure revealed the selectivity filter, a precise molecular pathway that allows potassium ions to pass while excluding sodium ions. His laboratory later determined the structures of numerous other channels, including voltage-gated potassium channels and the acetylcholine receptor, illuminating principles of gating and ion selectivity.
MacKinnon's transformative contributions have been recognized with numerous prestigious awards. In 1999, he received the Albert Lasker Award for Basic Medical Research. The pinnacle of his recognition came in 2003 when he was awarded the Nobel Prize in Chemistry "for structural and mechanistic studies of ion channels." He is also a recipient of the Gairdner Foundation International Award, the Passano Award, and the Louisa Gross Horwitz Prize. He has been elected to several esteemed academies, including the United States National Academy of Sciences, the American Academy of Arts and Sciences, and the Royal Society as a Foreign Member of the Royal Society.
MacKinnon is married to Alice Lee MacKinnon, a physician-scientist. The couple has three children and resides in New York City. An avid outdoorsman, he enjoys activities such as hiking and skiing. He is also known for his commitment to mentoring young scientists and advocating for basic scientific research in the public sphere.
Roderick MacKinnon's work provided the first atomic-resolution blueprint of an ion channel, resolving a long-standing mystery in physiology and launching a new era of structural neurobiology. His structures serve as foundational references for understanding electrical signaling in the nervous system, cardiac muscle contraction, and numerous other biological processes. The methodologies pioneered in his laboratory have been widely adopted for studying other challenging membrane proteins. His discoveries continue to inform the development of pharmaceuticals targeting ion channels for conditions such as cardiac arrhythmia, epilepsy, and autoimmune disease.
Category:American biophysicists Category:Nobel laureates in Chemistry Category:Rockefeller University faculty Category:Members of the United States National Academy of Sciences